Millennium Pharmacon International Stock Probability Of Bankruptcy

SDPC Stock  IDR 144.00  1.00  0.69%   
Millennium Pharmacon's likelihood of distress is under 9% at the moment. It has tiny risk of undergoing some form of financial distress in the near future. Bankruptcy prediction helps decision makers evaluate Millennium Pharmacon's chance of financial distress in relation to its going-concern outlook and evaluation. All items used in analyzing the odds of distress are taken from the Millennium balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Millennium Pharmacon Piotroski F Score and Millennium Pharmacon Altman Z Score analysis.
  

Millennium Probability Of Bankruptcy Analysis

Millennium Pharmacon's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Millennium Pharmacon Probability Of Bankruptcy

    
  Less than 9%  
Most of Millennium Pharmacon's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Millennium Pharmacon International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Millennium Pharmacon probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Millennium Pharmacon odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Millennium Pharmacon International financial health.
Please note, there is a significant difference between Millennium Pharmacon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Millennium Pharmacon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Millennium Pharmacon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Millennium Pharmacon International has a Probability Of Bankruptcy of 9.0%. This is 79.21% lower than that of the Health Care Providers & Services sector and 58.6% lower than that of the Health Care industry. The probability of bankruptcy for all Indonesia stocks is 77.4% higher than that of the company.

Millennium Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Millennium Pharmacon's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Millennium Pharmacon could also be used in its relative valuation, which is a method of valuing Millennium Pharmacon by comparing valuation metrics of similar companies.
Millennium Pharmacon is currently under evaluation in probability of bankruptcy category among related companies.

Millennium Fundamentals

About Millennium Pharmacon Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Millennium Pharmacon International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Millennium Pharmacon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Millennium Pharmacon International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Millennium Pharmacon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Millennium Pharmacon's short interest history, or implied volatility extrapolated from Millennium Pharmacon options trading.

Currently Active Assets on Macroaxis

Check out Millennium Pharmacon Piotroski F Score and Millennium Pharmacon Altman Z Score analysis.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Millennium Stock analysis

When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Correlations
Find global opportunities by holding instruments from different markets
Please note, there is a significant difference between Millennium Pharmacon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Millennium Pharmacon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Millennium Pharmacon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.